1 rich Libsyn https://www.libsyn.com 90 600 Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos’/Resilient's trials. Update to episode #68. The Psymposia Podcast http://plusthree.libsyn.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41008680/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/ed3037/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/201162575